ChartFilter logo - Stock Analysis Software

Return on Capital (ROC), Return on Invested Capital (ROIC) and Return on Equity (ROE):
Measurement and Implications by Dr. Aswath Damodaran

Return to index Return to document index

Effect on Returns

Since the capitalization of R&D expenses affects both the operating income and the book value of equity, it will inevitably also affect the measured returns on both capital and equity. The direction and magnitude of the effect will depend upon:

a. The amortizable life of R&D: Since the value of the research asset is computed based upon the amortizable life, it will increase as the life increases. Thus, the effect of R&D on the invested capital will be greater in sectors like pharmaceuticals, where the amortizable life is longer, than in software, where the life is much shorter.13

b. Growth in R&D over time: The effect of R&D on operating income is a function of the difference between the current year's expense and the cumulated amortization of prior year expenses. This difference will be largest (most positive) for firms where R&D expenses have grown substantially over time, will decrease as the growth rate decreases, becoming zero for mature firms with level R&D expenses over time. It is even possible for it to become negative, if R&D expenses are decreasing over time.

Bringing these two factors together, capitalizing R&D expenses is most likely to increase the computed return on capital (equity) for high growth firms in sectors where it takes time for research to be commercialized and to decrease return on capital (equity) for mature firms in the same sectors. The effect of capitalization will be smaller for firms in businesses where research tends to pay off quickly in the form of commercial products. The effect of capitalizing R&D on returns will also depend upon the level of preadjusted returns. Firms that report high returns on a pre-adjustment basis are more likely to see their returns go down, post-adjustment. The direction of the effect can be captured by comparing the pre-adjustment return on capital (equity) to the ratio of the R&D adjustment to earnings and the R&D effect on invested capital.

 

13 It is not atypical for a pharmaceutical firm to have to wait 10-12 years for research to pay off.

 

See Technical Indicators

Fundamental Analysis
Quick Overview
External Drivers
Internal Drivers
 
Balance Sheet items
Calculated Ratios / Fundamental valuation methods

Efficiency Ratios

Overvalued/Undervalued Ratios
(Equity position and coverage)

Liquidity Ratios

Calculated Ratios

 

 

Products | Advertise on ChartFilter.com | Support | Contact | Links | Affiliate Program

 Free Trial   -   Login   -   Email  

2008 © ChartFilter.com | Privacy | Terms of Use

Historical and current end-of-day data provided by Interactive Data Corp. and subject to terms of use.
Dow Jones Industrial Average is copyright Dow Jones & Company, Inc.

Powered by MHP Systems Inc.